After removal of the MBP tag, the cytotoxicity of HER2(scFv)-PE24B was tested against four breast cancer cell lines differing in surface HER2 level using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assays. This evidence concerns the gene ERBB2 and breast carcinoma.